Goldshleger Ilya — SEC Form 4 filings
SEC reporting owner CIK 1874147. 31 Form 4 filings on record with FilingPulse; latest filed 2026-09-09.
Transaction summary — filings shown
Covers all 31 filings on record, filed 2024-01-09 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 55 legs across 23 filings — 152,965 shares, $7,402,882 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 97.
- Largest priced transaction: sale of 5,000 shares @ $56.00 ($280,000) in RxSight, Inc., filed 2024-02-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RxSight, Inc. (RXST) | Chief Operating Officer | 31 | — | 55 legs · 152,965 sh · $7,402,882 | 97 |
Form 4 filings — Goldshleger Ilya
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-09 | 4 | RxSight, Inc. (RXST) | Disposition to issuer (D): 98,367 (derivative) · Disposition to issuer (D): 120,000 (derivative) · Disposition to issuer (D): 92,200 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 125,000 (derivative) · Grant/award (A): 73,960 (derivative) · +4 more | EDGAR |
| 2026-09-02 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 5,370 · Sale (S): 2,041 @ $6.96 · Option exercise (M): 5,370 (derivative) @ $0 | EDGAR |
| 2026-04-20 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 12,489 @ $4.13 · Option exercise (M): 12,489 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | RxSight, Inc. (RXST) | Grant/award (A): 32,218 (derivative) @ $0 | EDGAR |
| 2025-09-26 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 15,096 @ $4.34 · Option exercise (M): 8,349 @ $4.13 · Option exercise (M): 5,416 (derivative) @ $0 · Option exercise (M): 9,680 (derivative) @ $0 · Option exercise (M): 8,349 (derivative) @ $0 | EDGAR |
| 2025-02-27 | 4 | RxSight, Inc. (RXST) | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-12-03 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 3,105 @ $15.08 · Sale (S): 3,105 @ $46.08 · Option exercise (M): 3,105 (derivative) @ $0 | EDGAR |
| 2024-11-26 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 3,100 @ $15.08 · Sale (S): 3,100 @ $45 · Option exercise (M): 3,100 @ $15.08 · Sale (S): 3,100 @ $45.88 · Option exercise (M): 3,100 (derivative) @ $0 · Option exercise (M): 3,100 (derivative) @ $0 | EDGAR |
| 2024-11-18 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 4,875 @ $15.08 · Sale (S): 4,875 @ $46 · Option exercise (M): 3,100 @ $15.08 · Sale (S): 3,067 @ $45 · Sale (S): 33 @ $45.07 · Option exercise (M): 4,875 (derivative) @ $0 · +1 more | EDGAR |
| 2024-11-14 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 1,330 @ $15.08 · Sale (S): 1,330 @ $46.13 · Option exercise (M): 1,330 (derivative) @ $0 | EDGAR |
| 2024-11-08 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 3,100 @ $15.08 · Sale (S): 2,900 @ $54.96 · Sale (S): 200 @ $55.53 · Option exercise (M): 3,100 (derivative) @ $0 | EDGAR |
| 2024-11-05 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 3,100 @ $15.08 · Sale (S): 2,840 @ $50.98 · Sale (S): 260 @ $51.74 · Option exercise (M): 3,100 (derivative) @ $0 | EDGAR |
| 2024-10-31 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 3,105 @ $15.08 · Sale (S): 3,105 @ $51.91 · Option exercise (M): 3,105 (derivative) @ $0 | EDGAR |
| 2024-10-28 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 3,100 @ $15.08 · Sale (S): 3,100 @ $49.79 · Option exercise (M): 3,100 @ $15.08 · Sale (S): 3,100 @ $50.64 · Option exercise (M): 3,100 (derivative) @ $0 · Option exercise (M): 3,100 (derivative) @ $0 | EDGAR |
| 2024-10-22 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 3,100 @ $15.08 · Sale (S): 3,100 @ $49.68 · Option exercise (M): 3,100 (derivative) @ $0 | EDGAR |
| 2024-10-18 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 3,100 @ $15.08 · Sale (S): 3,100 @ $49.78 · Option exercise (M): 3,105 @ $15.08 · Sale (S): 3,002 @ $50.07 · Sale (S): 69 @ $50.56 · Sale (S): 34 @ $50.59 · +2 more | EDGAR |
| 2024-10-15 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 3,105 @ $15.08 · Sale (S): 3,105 @ $48.82 · Option exercise (M): 3,100 @ $15.08 · Sale (S): 3,100 @ $50.19 · Option exercise (M): 3,100 @ $15.08 · Sale (S): 3,100 @ $50.09 · +3 more | EDGAR |
| 2024-10-08 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 3,100 @ $15.08 · Sale (S): 2,866 @ $47.96 · Sale (S): 28 @ $48.47 · Sale (S): 206 @ $48.65 · Option exercise (M): 3,100 @ $15.08 · Sale (S): 3,100 @ $48.26 · +2 more | EDGAR |
| 2024-09-30 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 3,105 @ $15.08 · Sale (S): 3,105 @ $49.29 · Option exercise (M): 3,100 @ $15.08 · Sale (S): 1,652 @ $48.69 · Sale (S): 1,448 @ $49.38 · Option exercise (M): 3,105 (derivative) @ $0 · +1 more | EDGAR |
| 2024-09-23 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 3,100 @ $15.08 · Sale (S): 3,100 @ $53.19 · Option exercise (M): 3,100 @ $15.08 · Sale (S): 2,950 @ $52.62 · Sale (S): 150 @ $53.53 · Option exercise (M): 3,100 (derivative) @ $0 · +1 more | EDGAR |
| 2024-09-18 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 3,100 @ $15.08 · Sale (S): 3,100 @ $56.11 · Option exercise (M): 3,100 (derivative) @ $0 | EDGAR |
| 2024-08-08 | 4 | RxSight, Inc. (RXST) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-08-06 | 4 | RxSight, Inc. (RXST) | Sale (S): 1,145 @ $38.80 · Sale (S): 1,855 @ $39.43 · Sale (S): 1,087 @ $38.83 · Sale (S): 1,913 @ $39.51 · Sale (S): 1,827 @ $39.04 · Sale (S): 1,173 @ $39.73 | EDGAR |
| 2024-05-20 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 15,667 @ $3.93 · Option exercise (M): 4,840 @ $4.13 · Option exercise (M): 4,264 @ $4.34 · Option exercise (M): 15,667 (derivative) @ $0 · Option exercise (M): 4,840 (derivative) @ $0 · Option exercise (M): 4,264 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | RxSight, Inc. (RXST) | Grant/award (A): 92,200 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 5,000 @ $23.04 · Sale (S): 5,000 @ $52 · Option exercise (M): 10,000 @ $23.04 · Sale (S): 5,000 @ $53 · Sale (S): 5,000 @ $54 · Option exercise (M): 10,000 @ $23.04 · +5 more | EDGAR |
| 2024-02-12 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 5,365 @ $18.90 · Option exercise (M): 5,000 @ $23.04 · Sale (S): 5,365 @ $50.50 · Sale (S): 5,000 @ $51 · Option exercise (M): 5,365 (derivative) @ $0 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 6,539 @ $18.90 · Option exercise (M): 590 @ $23.04 · Sale (S): 3,539 @ $49 · Sale (S): 3,000 @ $49.50 · Sale (S): 590 @ $50 · Option exercise (M): 6,539 (derivative) @ $0 · +1 more | EDGAR |
| 2024-01-22 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 5,000 @ $18.90 · Sale (S): 5,000 @ $48 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-01-10 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 5,000 @ $18.90 · Sale (S): 5,000 @ $47 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 15,000 @ $15.08 · Sale (S): 5,000 @ $42 · Sale (S): 5,000 @ $43 · Sale (S): 5,000 @ $45 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1874147 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →